Delivery Order SPE2DB20D1100-SPE2DB25FC6B3
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,063.60 on September 3, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, an injectable rheumatoid arthritis and autoimmune disease treatment. This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a single-item pharmaceutical procurement with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,656.85 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable medication used to treat autoimmune conditions. This contract, awarded on October 21, 2025, with an ultimate completion date of October 22, 2025, is a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,886.97 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a brand-name rheumatoid arthritis and immunological disease treatment. This firm fixed-price, competitively awarded delivery order was executed on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $3,084.90 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on July 17, 2025, with completion targeted for July 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. HUMIRA is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis, psoriasis, Crohn's disease,...
- The Defense Logistics Agency awarded a delivery order valued at $3,792.24 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a subcutaneous injection used to treat autoimmune conditions. This firm fixed-price, competitively awarded delivery order was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation....
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and was awarded on June 16, 2025, without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $32,943.62 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and was awarded competitively without a set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $3,043.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of HUMIRA(CF) Pen 40 mg/0.4 mls, a biological immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions. The contract has no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order represents...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,542.07 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. HUMIRA is a leading biologic immunosuppressant medication used to treat various...
- The Defense Logistics Agency awarded a delivery order valued at $2,476.54 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating rheumatoid arthritis and other inflammatory conditions. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with a completion date of April 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC6B3Delivery Order
The Defense Logistics Agency awarded a $3,437.98 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a subcutaneous auto-injector medication used to treat rheumatoid arthritis, Crohn's disease, and other autoimmune conditions. The contract, awarded on May 30, 2025, with an ultimate completion date of June 2, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. This award represents a small-value transaction typical of the company's extensive portfolio of pharmaceutical supply deliveries to federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp has demonstrated its capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains, positioning it as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 5/30/25 |